Funded Tech Companies
Beyang Therapeutics
Based in Shanghai, Beyang Therapeutics has funding from Shanghai Healthcare Capital, Legend Capital and Root Ventures.
Company Overview
Company Name
Beyang Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
No. 103 Cailun Rd. 1-3A01
Shanghai, 201203
China
Shanghai, 201203
China
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
BEYANG Therapeutics Co., Ltd. is an innovative biopharmaceutical company that employs its proprietary ExCEED platforms to accelerate the process of new drug discovery and development in disease areas of significant unmet medical needs. Founders and management team each has more than 20 years of experience and worked at Pfizer, Merck, Astra Zeneca, Schring Plough and Hengrui previously. They are quite experienced in drug target selection, CADD, AIDD, bioassay screening and optimization, as well as DMPK. Together they have contributed to the development of more than 10 clinical candidate molecules, of which three drugs (Sunitinib/Axitinib/Crizotinib) have been approved by FDA and NMPA.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/12/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Qiyue Hu
VP - Engineering
Shek Chan
VP - R & D
Suxing Liu
Company Investors
- Shanghai Healthcare Capital
- Legend Capital
- Root Ventures
- Shanghai Sci-Tech Innovation Center Capital
- Yuanbio Venture Capital
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs